"Linagliptin and Metformin Hydrochloride"

Linagliptin and Metformin Hydrochloride
LINALIGLIP 2.5/500  are two different medications used in the treatment of type 2 diabetes mellitus. They are often prescribed together as a combination therapy to help control blood sugar levels in individuals with diabetes.
Linagliptin: Linagliptin is a medication that belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the levels of certain hormones called incretins in the body. Incretins help to regulate blood sugar levels by stimulating the release of insulin and reducing the production of glucose by the liver. By inhibiting the enzyme DPP-4, linagliptin prolongs the action of incretins, leading to better blood sugar control.
Metformin Hydrochloride: Metformin is a medication classified as a biguanide. It is one of the most commonly prescribed oral antidiabetic drugs. Metformin works by decreasing the production of glucose in the liver and increasing the sensitivity of muscle cells to insulin. It also helps to improve the uptake and utilization of glucose by peripheral tissues, such as muscle and fat, thus lowering blood sugar levels.
Combining  LINALIGLIP 2.5/500  in a single tablet provides a complementary effect, as they target different aspects of glucose regulation in the body. This combination therapy can be more effective in achieving glycemic control compared to using either medication alone. It is usually prescribed for individuals with type 2 diabetes who do not achieve adequate blood sugar control with diet and exercise or metformin monotherapy.
As with any medication, LINALIGLIP 2.5/500  may cause side effects, and their use should be managed under the supervision of a healthcare professional. Common side effects include gastrointestinal issues like nausea, diarrhea, and abdominal discomfort.
For further information please contact:
info@sterispharma.com
order now - https://www.sterisonline.com/product/linaliglip-2-5-500-134273